Ono J, Hutson D G, Dombro R S, Zeppa R, Katsuki T
Gastroenterol Jpn. 1984 Apr;19(2):99-103. doi: 10.1007/BF02806930.
Hepatic insulinase activity was studied in cirrhosis in an attempt to explain the hyperinsulinemia known to occur in this disease. Liver tissue was obtained during laparotomy in seven patients with cirrhosis of the liver and five patients without liver disease. Insulin degradation was significantly decreased in the cirrhotic liver at each time interval measured (p less than 0.05). Insulinase inhibitor activity was measured in the plasma of 12 patients with cirrhosis of the liver and six controls. There was no significant difference between the two groups. Decreased insulinase activity in cirrhosis may account, in part, for the hyperinsulinemia seen in this disease.
为了解释肝硬化患者中已知存在的高胰岛素血症,对肝硬化患者的肝脏胰岛素酶活性进行了研究。在七名肝硬化患者和五名无肝脏疾病患者的剖腹手术过程中获取肝脏组织。在每个测量的时间间隔,肝硬化肝脏中的胰岛素降解均显著降低(p<0.05)。在12名肝硬化患者和6名对照者的血浆中测量了胰岛素酶抑制剂活性。两组之间无显著差异。肝硬化中胰岛素酶活性降低可能部分解释了该疾病中出现的高胰岛素血症。